BioPharm America™ 2015 convenes over 800 global life science investors, leaders in Boston

The eighth edition of BioPharm America™ 2015 life science partnering event wrapped up last week in Boston with overwhelming success. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the event brought together cutting edge biotech companies and early stage startups, with executives from global pharmaceutical companies, finance, investors and service partners.

The event was attended by 853 delegates from 524 companies representing 27 countries. 2,274 one-to-one partnering meetings were held at the event where 657 licensing opportunities were on offer.

New this year was the successful Biotech Startup Day which focused on new and innovative startup companies who presented directly to Boston’s leading financiers, pharma dealmakers and biotech business executives. A dedicated Partnerships in Regenerative Medicine and Advanced Therapies Day was also added, which convened top luminaries to discuss ways to advance the field.

“This year was a groundbreaking year for the life science industry in terms of deals and IPOs, and the energy was evident at BioPharm America,” said Anna Chrisman, Group Managing Director of EBD Group. “We continue to add new elements to the event that reflect the market, and the new program offerings this year, combined with the energy from the startups involved, resulted in one of our best events yet.”


“BioPharm America continues to draw a diverse group of industry leaders from around the world for productive partnering meetings,” said Robert K. Coughlin, President and CEO of MassBio. “These meetings are essential for the growth of our industry and the development of new treatments because, as we have seen increasingly over the past few years, collaboration is critical for the future of innovation here in Massachusetts and beyond.”


Videos and articles from BioPharm America 2015 are available online at partnering360® Insight.


BioPharm America 2016 will be held September 13–15 at Boston Marriott Copley Place in the heart of Boston.

# # #

Additional links and information:

Follow BioPharm America 2015 on Twitter:  @EBDGroup (hashtag: #BPA15).

Online Press Kit service for BioPharm America™ 2015 is available from PR Newswire to enhance your public relations efforts.


About  EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® Group
  • Biolatam®, facilitating partnering among global life sciences executives in Latin America’s vibrant life science hubs


EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit


Erin Righetti

EBD Group

+1 760 930 0500